FDA medication error draft guidance to come by Sept. 30

Packaging, such as container/carton labels, will be considered by the agency in an attempt to reduce errors.

Hp 19431 I Stock Med Errors 000009856897 Small
ModernMedicine reports that the U.S. Food & Drug Administration “has made a commitment to publish a draft guidance to reduce medication errors by Sept. 30.”

According to the report, the FDA was looking for comments on reducing errors that could be connected to “the design of container labels, carton labels, and packaging.” Proprietary naming errors can stem from sources such as look-alike/sound-alike names, abbreviations, not recognizing the active ingredient, and encoded numerals.

An alarming point made in the Modern Medicine article: “A third of medication errors, including 30% of fatal errors reported to the Institute for Safe Medication Practices, may be attributed to packaging and labeling, FDA noted.”

Here's a look at several revealing and frightening statistics pertaining to medication errors…

--Jim Butschli, Healthcare Packaging editor
Fresh from the show floor: pharma packaging innovations for 2026
Serialization mandates. Containment demands. Sterile barrier requirements. Our editors found the pharma packaging innovations addressing your biggest challenges at PACK EXPO Las Vegas. Get your free curated report now.
GET YOUR COPY
Fresh from the show floor: pharma packaging innovations for 2026